Pricing

Log inSign up

Eyenovia

21 people · 0 jobs
‌

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology.

Industries

Pharmaceutical

Headquarters

New York, United States

Employees

51-200

Links

Org chart

Sean Ianchulev
CEO, Chief Medical Officer, Director & Founder
Collapse
Greg Bennett
VP of Clinical Program Strategy & Development
LG
Lauren Grizzard
Vice President Of Regulatory Affairs & Quality Assurance
Louis Katayama
Manager, Medical Affairs And Clinical Operations
Norbert Lowe
VP, Commercial Operations
Enrico Brambilla
VP Of Product Research And Development
DC
Daryn Caldwell
Director, Commercial Operations | Training & Development

Board & advisors

Charles Mather
Director
Mark Bullimore
Scientific Advisor
Pamela Gallin
Scientific Advisor
James C. Tsai
Scientific Advisor
Robert N. Weinreb
Scientific Advisor
Francis Mah
Scientific Advisor
Jason Jones
Scientific Advisor
April Jasper
Scientific Advisor
Rachel Jacobson
Independent Director
Stephen Benjamin
Independent Director
Ram Palanki
Independent Director
Ellen Strahlman
Independent Director

Offices

Similar companies

Xeris Pharmaceuticals

3 followers

Cosette Pharmaceuticals

1 follower

Bristol-Myers Squibb

275 followers

NYU Langone Health

34 followers

West Pharmaceutical Services

10 followers

Curia Global

7 followers

AbbVie

294 followers

Navitus Health

6 followers

Corcept Therapeutics

4 followers

Catalyst Pharmaceuticals

3 followers

Arthritis Knee Pain Centers

2 followers

Explore companies